203 related articles for article (PubMed ID: 32424196)
41. Which type of cancer patients are more susceptible to the SARS-COX-2: Evidence from a meta-analysis and bioinformatics analysis.
Wang B; Huang Y
Crit Rev Oncol Hematol; 2020 Sep; 153():103032. PubMed ID: 32599375
[TBL] [Abstract][Full Text] [Related]
42. Dual Challenge of Cancer and COVID-19: Impact on Health Care and Socioeconomic Systems in Asia Pacific.
De Guzman R; Malik M
JCO Glob Oncol; 2020 Jun; 6():906-912. PubMed ID: 32589462
[TBL] [Abstract][Full Text] [Related]
43. Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy.
Di Lorenzo G; Buonerba L; Ingenito C; Crocetto F; Buonerba C; Libroia A; Sciarra A; Ragone G; Sanseverino R; Iaccarino S; Napodano G; Imbimbo C; Leo E; Kozlakidis Z; De Placido S
Oncology; 2020; 98(10):743-747. PubMed ID: 32570240
[TBL] [Abstract][Full Text] [Related]
44. COVID-19 in patients with lung cancer.
Luo J; Rizvi H; Preeshagul IR; Egger JV; Hoyos D; Bandlamudi C; McCarthy CG; Falcon CJ; Schoenfeld AJ; Arbour KC; Chaft JE; Daly RM; Drilon A; Eng J; Iqbal A; Lai WV; Li BT; Lito P; Namakydoust A; Ng K; Offin M; Paik PK; Riely GJ; Rudin CM; Yu HA; Zauderer MG; Donoghue MTA; Łuksza M; Greenbaum BD; Kris MG; Hellmann MD
Ann Oncol; 2020 Oct; 31(10):1386-1396. PubMed ID: 32561401
[TBL] [Abstract][Full Text] [Related]
45. COVID-19 and cancer.
Sharpless NE
Science; 2020 Jun; 368(6497):1290. PubMed ID: 32554570
[No Abstract] [Full Text] [Related]
46. Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era.
Maio M; Hamid O; Larkin J; Covre A; Altomonte M; Calabrò L; Vardhana SA; Robert C; Ibrahim R; Anichini A; Wolchok JD; Giacomo AMD
Clin Cancer Res; 2020 Aug; 26(16):4201-4205. PubMed ID: 32540850
[TBL] [Abstract][Full Text] [Related]
47. High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.
Assaad S; Avrillon V; Fournier ML; Mastroianni B; Russias B; Swalduz A; Cassier P; Eberst L; Steineur MP; Kazes M; Perol M; Michallet AS; Rey P; Erena-Penet AS; Morel A; Brahmi M; Dufresne A; Tredan O; Chvetzoff G; Fayette J; de la Fouchardiere C; Ray-Coquard I; Bachelot T; Saintigny P; Tabutin M; Dupré A; Nicolas-Virelizier E; Belhabri A; Roux PE; Fuhrmann C; Pilleul F; Basle A; Bouhamama A; Galvez C; Herr AL; Gautier J; Chabaud S; Zrounba P; Perol D; Blay JY
Eur J Cancer; 2020 Aug; 135():251-259. PubMed ID: 32540204
[TBL] [Abstract][Full Text] [Related]
48. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis.
Meng Y; Lu W; Guo E; Liu J; Yang B; Wu P; Lin S; Peng T; Fu Y; Li F; Wang Z; Li Y; Xiao R; Liu C; Huang Y; Lu F; Wu X; You L; Ma D; Sun C; Wu P; Chen G
J Hematol Oncol; 2020 Jun; 13(1):75. PubMed ID: 32522278
[TBL] [Abstract][Full Text] [Related]
49. Cancer and COVID-19: Unmasking their ties.
Addeo A; Friedlaender A
Cancer Treat Rev; 2020 Aug; 88():102041. PubMed ID: 32516704
[TBL] [Abstract][Full Text] [Related]
50. Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient Data.
Giannakoulis VG; Papoutsi E; Siempos II
JCO Glob Oncol; 2020 Jun; 6():799-808. PubMed ID: 32511066
[TBL] [Abstract][Full Text] [Related]
51. The Effect of Coronavirus (COVID-19) on Breast Cancer Teamwork: A Multicentric Survey.
Vanni G; Materazzo M; Santori F; Pellicciaro M; Costesta M; Orsaria P; Cattadori F; Pistolese CA; Perretta T; Chiocchi M; Meucci R; Lamacchia F; Assogna M; Caspi J; Granai AV; DE Majo A; Chiaravalloti A; D'Angelillo MR; Barbarino R; Ingallinella S; Morando L; Dalli S; Portarena I; Altomare V; Tazzioli G; Buonomo OC
In Vivo; 2020 Jun; 34(3 Suppl):1685-1694. PubMed ID: 32503830
[TBL] [Abstract][Full Text] [Related]
52. ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of thyroid nodules and cancer.
Vrachimis A; Iakovou I; Giannoula E; Giovanella L
Eur J Endocrinol; 2020 Jul; 183(1):G41-G48. PubMed ID: 32438345
[TBL] [Abstract][Full Text] [Related]
53. COVID-19 and liver cancer clinical trials: Not everything is lost.
D'Alessio A; Personeni N; Pressiani T; Bozzarelli S; Smiroldo V; Simonelli M; Lleo A; Santoro A; Rimassa L
Liver Int; 2020 Jul; 40(7):1541-1544. PubMed ID: 32433799
[No Abstract] [Full Text] [Related]
54. Management of immune checkpoint therapy for patients with cancer in the face of COVID-19.
Shen C; Li Q; Wei Y; Li Y; Li J; Tao J
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33303577
[TBL] [Abstract][Full Text] [Related]
55. Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection.
Gambichler T; Reuther J; Scheel CH; Susok L; Kern P; Becker JC
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33207589
[TBL] [Abstract][Full Text] [Related]
56. Differences in terms of presentation and outcomes between patients with lung cancer as opposed to other solid organ cancer after infection with SARS-CoV-2: protocol for a systematic review.
Chen H; Shi J; Shi W; Xu H; Duan C; Fan Q; Wang Y; Li H
BMJ Open; 2020 Nov; 10(11):e041790. PubMed ID: 33172947
[TBL] [Abstract][Full Text] [Related]
57. Safety of patients and providers in lung cancer surgery during the COVID-19 pandemic.
Chang SH; Zervos M; Kent A; Chachoua A; Bizekis C; Pass H; Cerfolio RJ
Eur J Cardiothorac Surg; 2020 Dec; 58(6):1222-1227. PubMed ID: 33150417
[TBL] [Abstract][Full Text] [Related]
58. A Nasopharyngeal Carcinoma Patient With COVID-19 Infection After Immunotherapy: A Case Report and Literature Review.
Zhai M; Zhang S
In Vivo; 2020; 34(6):3753-3756. PubMed ID: 33144494
[TBL] [Abstract][Full Text] [Related]
59. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
Lièvre A; Turpin A; Ray-Coquard I; Le Malicot K; Thariat J; Ahle G; Neuzillet C; Paoletti X; Bouché O; Aldabbagh K; Michel P; Debieuvre D; Canellas A; Wislez M; Laurent L; Mabro M; Colle R; Hardy-Bessard AC; Mansi L; Colomba E; Bourhis J; Gorphe P; Pointreau Y; Idbaih A; Ursu R; Di Stefano AL; Zalcman G; Aparicio T;
Eur J Cancer; 2020 Dec; 141():62-81. PubMed ID: 33129039
[TBL] [Abstract][Full Text] [Related]
60. The Risk and Impact of COVID-19 Pandemic on Immunosuppressed Patients: Cancer, HIV, and Solid Organ Transplant Recipients.
Mohammed AH; Blebil A; Dujaili J; Rasool-Hassan BA
AIDS Rev; 2020; 22(3):151-157. PubMed ID: 33118527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
